Verve Therapeutics
Pete Cotter is a seasoned professional in the field of molecular biology and analytical development, currently serving as Director of Molecular Biology and Potency Analytics at Verve Therapeutics since June 2022. Prior experience includes roles as Associate Director and Senior Scientist at Vor Biopharma, and as an Analytical Development Scientist II at CRISPR Therapeutics. Previous positions also include Research Scientist I at Bristol-Myers Squibb, Research Associate at Wyeth, and Research Technologist at Massachusetts General Hospital. Pete Cotter earned a degree from Texas Tech University between 1997 and 2003.
This person is not in any teams
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.